Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bio-Rad Laboratories Inc. (ZBIO)

10.0204   0 (0%) 09-20 20:04
Open: 10.1 Pre. Close: 10.0204
High: 10.1 Low: 9.3419
Volume: 27,228 Market Cap: 0M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 519.552 - 521.087 521.087 - 522.807
Low: 508.354 - 510.256 510.256 - 512.387
Close: 511.807 - 514.66 514.66 - 517.855

Technical analysis

as of: 2020-09-18 4:28:39 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 617.81     One year: 721.61
Support: Support1: 494.27    Support2: 472.84
Resistance: Resistance1: 528.95    Resistance2: 617.81
Pivot: 503.72
Moving Average: MA(5): 509.05     MA(20): 506.67
MA(100): 483.20     MA(250): 411.38
MACD: MACD(12,26): -0.03     Signal(9): -1.08
Stochastic oscillator: %K(14,3): 70.26     %D(3): 64.40
RSI: RSI(14): 54.87
52-week: High: 540.06  Low: 309.38  Change(%): 51.6
Average Vol(K): 3-Month: 19066  10-Days: 16286

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
BIO has closed below upper band by 25.1%. Bollinger Bands are 9.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 17 Aug 2020
Opko Health - Consensus Indicates Potential 64.6% Upside - DirectorsTalk Interviews

Mon, 10 Aug 2020
Dr. Reddy's Laboratories Ltd - Consensus Indicates Potential -22.2% Downside - DirectorsTalk Interviews

Mon, 10 Aug 2020
Kindred Biosciences - Consensus Indicates Potential 191.7% Upside - DirectorsTalk Interviews

Wed, 29 Jul 2020
Kindred Biosciences - Consensus Indicates Potential 251.5% Upside - DirectorsTalk Interviews

Tue, 28 Jul 2020
Open Orphan awarded contract from Codagenix Inc. New York USA for COVID-19 vaccine trial - DirectorsTalk Interviews

Tue, 07 Jul 2020
Kindred Biosciences - Consensus Indicates Potential 201.8% Upside - DirectorsTalk Interviews

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 25
Shares Float (M) 21
% Held by Insiders 14.29
% Held by Institutions 79.15
Shares Short (K) 558
Shares Short P. Month (K) 508

Stock Financials

EPS 64.500
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 247.770
Profit Margin 84.89
Operating Margin 11.88
Return on Assets (ttm) 1.9
Return on Equity (ttm) 30.3
Qtrly Rev. Growth -6.2
Gross Profit (p.s.) 51.240
Sales Per Share 93.127
EBITDA (p.s.) 16.632
Qtrly Earnings Growth 61.40
Operating Cash Flow (M) 414
Levered Free Cash Flow (M) 340

Stock Valuations

PE Ratio 7.99
PEG Ratio
Price to Book value 2.08
Price to Sales 5.53
Price to Cash Flow 30.56

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.